Jupiter Endovascular, Inc.

About Jupiter Endovascular, Inc.

Jupiter Endovascular aims to reinvent endovascular medicine with their Endoportal Control™ technology. Their vision spans the breadth of cardiovascular disease, focusing on reimagining therapies for millions of patients, with an initial focus on Pulmonary Embolism.

Products & Services

Endoportal Control™:A technology designed to combine the precision and control of surgery with the safety and simplicity of catheter interventions.

Vertex Pulmonary Embolectomy System:A system using Endoportal Control™ for treating Pulmonary Embolism, currently under clinical study and pivotal trials in the U.S.

Specialties

Endovascular Medicine Cardiovascular Disease Treatment Pulmonary Embolism Therapy Catheter-Based Interventions

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series B T: - FT: Series B	A: 40000000 MR: - FA: over $40 million FAN: 40000000	D: 2025-10-07 FD: 2025-10-07	4 investors
2	RT: New Round T: - FT: New Round	A: 21000000 MR: - FA: $21 million FAN: 21000000	D: 2024-08-15 FD: 2024-08-15	2 investors

Series B Latest

2025-10-07

$40.0M

4 investors (Pro only)

New Round 2024-08-15

$21.0M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

C

Carl St. Bernard

Chief Executive Officer

F

Fred Ong

Chief Financial Officer

C

Chuck Love

Chief Science Officer

G

Garrett Gomes

VP of Product Development

C

Cheuk Tang

VP of QA & RA

A

Aadi Chachad

Sr. Director of Clinical Affairs

View 6 more team members with Pro

Unlock Full Team Directory

Recent News